Invicro (United Kingdom)

Recent papers from Invicro (United Kingdom)

1. [18F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418EJNMMI Research · 2026
2. Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [11C]UCB-J positron emission tomography studyNeuropsychopharmacology · 2026
3. External Validation of Joint Propagation Model‐Based Tau PET CenTauR unitsAlzheimer s & Dementia · 2025
4. Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsMovement Disorders · 2025
5. Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's disease.2025
6. GABAA receptor availability in clinical high-risk and first-episode psychosis: a [11C]Ro15-4513 positron emission tomography studyMolecular Psychiatry · 2025
7. Evaluation of Mitochondrial Complex 1 Density with [¹⁸F]BCPP-EF in a Murine Model and Individuals with Friedreich AtaxiaJournal of Nuclear Medicine · 2025
8. PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistryScience Translational Medicine · 2025
9. The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging studyTranslational Psychiatry · 2025
10. Mitochondria and Cognition: An [18F]BCPP-EF Positron Emission Tomography Study of Mitochondrial Complex I Levels and Brain Activation During Task SwitchingBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2025
11. PET imaging of an antisense oligonucleotide in the living non-human primate brain using click chemistry2025
12. Working memory processes and the histamine-3 receptor in schizophrenia: a [11C]MK-8278 PET-fMRI studyPsychopharmacology · 2024
13. Targeting c-MET for Endoscopic Detection of Dysplastic Lesions within Barrett’s Esophagus Using EMI-137 Fluorescence ImagingClinical Cancer Research · 2024
14. Bexotegrast Shows Dose-Dependent Integrin αvβ6 Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical TrialAnnals of the American Thoracic Society · 2024
15. Preclinical in vitro and in vivo evaluation of [ ¹¹ C]ORM-13070 as PET ligand for alpha-2C adrenergic receptor occupancy using PET imaging in non-human primatesJournal of Cerebral Blood Flow & Metabolism · 2024
16. Study protocol for the iMarkHD study in individuals with Huntington's diseaseJournal of Huntington s Disease · 2024
17. Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associationsBrain · 2024
18. 6523 Kisspeptin Administration Does Not Induce Anxiety in HumansJournal of the Endocrine Society · 2024
19. 6953 Bridging the Gender Gap: Sexually Dimorphic Brain Responses in Distressing Low Sexual DesireJournal of the Endocrine Society · 2024
20. Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseSHILAP Revista de lepidopterología · 2024